Kezar Life Sciences, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
SUVRETTA CAPITAL MANAGEMENT, LLC | 11/14/2024 | 7.17 M | $5.54 M | 0.00% | 0.98% |
AVIDITY PARTNERS MANAGEMENT LP | 11/14/2024 | 5.03 M | $3.89 M | 0.00% | 0.69% |
TANG CAPITAL MANAGEMENT LLC | 11/14/2024 | 3.64 M | $2.81 M | 100.00% | 0.50% |
VANGUARD GROUP INC | 11/13/2024 | 2.74 M | $2.12 M | 0.00% | 0.38% |
AFFINITY ASSET ADVISORS, LLC | 11/13/2024 | 2.51 M | $1.94 M | 42.57% | 0.34% |
ORBIMED ADVISORS LLC | 11/14/2024 | 1.93 M | $1.49 M | 0.00% | 0.26% |
ACADIAN ASSET MANAGEMENT LLC | 11/12/2024 | 1.58 M | $1.22 M | -14.99% | 0.22% |
STONEPINE CAPITAL MANAGEMENT, LLC | 11/13/2024 | 1.49 M | $1.15 M | 41.97% | 0.20% |
TWO SIGMA ADVISERS, LP | 11/14/2024 | 1.40 M | $1.08 M | 13.36% | 0.19% |
RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 1.30 M | $1.00 M | 66.62% | 0.18% |
ACUITAS INVESTMENTS, LLC | 11/07/2024 | 1.23 M | $949,121 | 24.40% | 0.17% |
IKARIAN CAPITAL, LLC | 11/14/2024 | 1.07 M | $826,544 | 23.02% | 0.15% |
TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 901,765 | $697,245 | -21.46% | 0.12% |
QIMING U.S. VENTURES MANAGEMENT, LLC | 11/07/2024 | 828,711 | $638,107 | 0.00% | 0.11% |
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 828,578 | $640,656 | 100.00% | 0.11% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 626,912 | $484,834 | 14.98% | 0.09% |
MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 494,226 | $382,136 | -21.37% | 0.07% |
GOLDMAN SACHS GROUP INC | 11/14/2024 | 297,774 | $230,239 | -70.78% | 0.04% |
RBF CAPITAL, LLC | 11/14/2024 | 282,521 | $218,445 | 0.00% | 0.04% |
CITADEL ADVISORS LLC | 11/14/2024 | 245,462 | $189,791 | -49.20% | 0.03% |
MORGAN STANLEY | 11/14/2024 | 222,027 | $171,671 | 3,016.17% | 0.03% |
BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2024 | 208,985 | $161,587 | 38.87% | 0.03% |
SPHERA FUNDS MANAGEMENT LTD. | 11/14/2024 | 205,168 | $1.59 M | -90.00% | 0.03% |
STATE STREET CORP | 11/14/2024 | 185,941 | $143,770 | 0.00% | 0.03% |
MARQUETTE ASSET MANAGEMENT, LLC | 10/08/2024 | 178,056 | $137,673 | 0.00% | 0.02% |
SQUAREPOINT OPS LLC | 11/14/2024 | 98,502 | $76,162 | 141.21% | 0.01% |
AMUNDI | 11/13/2024 | 82,243 | $60,860 | 0.00% | 0.01% |
WELLS FARGO & COMPANY/MN | 11/13/2024 | 78,162 | $60,435 | -1.70% | 0.01% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 63,358 | $48,988 | 0.00% | 0.01% |
JANE STREET GROUP, LLC | 11/15/2024 | 59,541 | $46,037 | -89.16% | 0.01% |
XTX TOPCO LTD | 11/14/2024 | 52,148 | $40,321 | 256.10% | 0.01% |
QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 43,949 | $33,981 | -71.93% | 0.01% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 11/14/2024 | 28,421 | $21,975 | 5.22% | 0.00% |
POINT72 ASIA (SINGAPORE) PTE. LTD. | 11/14/2024 | 27,438 | $21,215 | -73.89% | 0.00% |
RVW WEALTH, LLC | 10/15/2024 | 23,765 | $18,375 | 0.00% | 0.00% |
VALENCE8 US LP | 11/12/2024 | 21,136 | $16,342 | 100.00% | 0.00% |
RETIREMENT CAPITAL STRATEGIES | 11/12/2024 | 15,000 | $11,598 | 0.00% | 0.00% |
CITADEL ADVISORS LLC | 11/14/2024 | 13,800 | $10,670 | 331.25% | 0.00% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 12,594 | $9,738 | -95.65% | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 11,600 | $8,969 | -89.32% | 0.00% |
AVANTAX ADVISORY SERVICES, INC. | 11/13/2024 | 11,110 | $8,590 | 0.00% | 0.00% |
HRT FINANCIAL LP | 11/12/2024 | 10,961 | $8,000 | -85.90% | 0.00% |
GROUND SWELL CAPITAL, LLC | 10/29/2024 | 10,800 | $8,351 | 100.00% | 0.00% |
ENGINEERS GATE MANAGER LP | 11/14/2024 | 10,564 | $8,168 | 100.00% | 0.00% |
GLOBAL RETIREMENT PARTNERS, LLC | 10/16/2024 | 10,000 | $7,732 | 0.00% | 0.00% |
TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 9,886 | $7,642 | -57.14% | 0.00% |
ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 4,666 | $3,596 | 376.12% | 0.00% |
SIMPLEX TRADING, LLC | 11/08/2024 | 3,785 | $2,000 | -0.08% | 0.00% |
FMR LLC | 11/13/2024 | 3,212 | $2,484 | -94.84% | 0.00% |
BANK OF AMERICA CORP /DE/ | 11/14/2024 | 1,703 | $1,316 | -98.38% | 0.00% |
Kezar Life Sciences, Inc.institutional Ownership - FAQ's
During the previous two years, 91 institutional investors and hedge funds held shares of Kezar Life Sciences, Inc.. The most heavily invested institutionals were:
SUVRETTA CAPITAL MANAGEMENT, LLC: 7.17 M
Avidity Partners Management LP: 5.03 M
TANG CAPITAL MANAGEMENT LLC: 3.64 M
VANGUARD GROUP INC: 2.74 M
Affinity Asset Advisors, LLC: 2.51 M
ORBIMED ADVISORS LLC: 1.93 M
5.16% of Kezar Life Sciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 40.60 M shares in the last 24 months. This purchase volume represents approximately $259.00 M in transactions.